Parsabiv

Drug List

Parsabiv

Drug Name

Parsabiv (Etelcalcetide)

Manufactured By

Amgen, Inc.

Drug Savings

Nationwide Prescription Connection (NPC) is an experienced advocacy service that helps connect patients to manufacturer provided free and discount programs. We can help the uninsured, under insured, those in the Medicare gap also known as the "doughnut hole", or even those needing help with expensive co-pays.  Our web site makes it easy for you to enter the medications you are taking, along with some basic patient information, and then finds the program that is right for you.

NPC's mission is your health. We recognize your need for help when you are applying for discount programs for your prescription medications. We consist of friendly and experienced advocates that not only know how these free and discount programs work, but are ready to help. We are available to take your call and answer any questions you may have as you search for the right program to fit your needs. We can also explain any supporting material you may need to provide as you apply for these programs. If for any reason you are denied, we also are experienced in the best appeals process with a high success rate.

Class

Treats Disease/Condition

Uses

Used to reduce the levels of parathyroid hormone in adults who have high levels of this hormone because of long-term kidney disease (secondary hyperparathyroidism).

How To Use

It is given by injection into a vein. It can also be given at the end of a haemodialysis session into the line that leads back from the dialysis machine to a patient's vein.

Side Effects

The most common side effects with Parsabiv (which may affect more than 1 in 10 people) are low calcium level in the blood, muscle spasm, diarrhea, nausea (feeling sick) and vomiting.

Drug Interactions

In Case of Overdose

There is no clinical experience with PARSABIV over-dosage. Over-dosage of PARSABIV may lead to hypocalcemia with or without clinical symptoms and may require treatment. Although PARSABIV is cleared by dialysis, hemodialysis has not been studied as a treatment for PARSABIV over-dosage. In the event of over-dosage, corrected serum calcium should be checked and patients should be monitored for symptoms of hypocalcemia, and appropriate measures should be taken.

In Case of Missed Dose

Storage